A glimpse into our research
The Biomedical Data Science group creates algorithms and software tools to identify diagnostic biomarker signatures, investigate mechanistic pathway and network alterations in disease-related omics data for drug target prioritisation, and screen drug-like molecules for selected protein targets. Our applications focus on the integrative analysis of multimodal data for neurodegenerative disorders, using omics, clinical, imaging, and digital biomarker data.
